Longitudinal quality of life data can pr
β
Ross Carter; Deborah D. Stocken; Payla Ghaneh; Simon R. Bramhall; Attila Olah; D
π
Article
π
2009
π
John Wiley and Sons
π
French
β 190 KB
## Abstract The European Study Group for Pancreatic Cancer (ESPACβ1) study is the largest study of adjuvant treatment for pancreatic ductal adenocarcinoma to date and confirmed a survival advantage for adjuvant chemotherapy but not for chemoradiation. The importance of parallel evaluation of surviv